Psychopathological dimensions of tinnitus and psychopharmacologic approaches in its treatment

General Hospital Psychiatry

Volumn 34, Issue 3, 2012, Pages 282-289

  Belli, Hasan ^a   Belli, Seyda ^a   Oktay, Mehmet Faruk ^a   Ural, Cenk ^a  

^a Bagcilar Education and Research Hospital   (Turkey)

Author keywords

Psychopathology; Psychopharmacology; Tinnitus

Indexed keywords

ACAMPROSATE; ALPRAZOLAM; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CAROVERINE; CLONAZEPAM; DIAZEPAM; GABAPENTIN; GLUTAMATE RECEPTOR ANTAGONIST; HYDROXYZINE; LAMOTRIGINE; LIDOCAINE; MEMANTINE; MIANSERIN; MIDAZOLAM; NORTRIPTYLINE; PAROXETINE; PLACEBO; SALICYLIC ACID; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID; SULPIRIDE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ANXIETY; ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DISTRESS SYNDROME; DOSE RESPONSE; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; EMOTIONALITY; FEMALE; HOSTILITY; HUMAN; HYPOCHONDRIASIS; HYSTERIA; IMPULSIVENESS; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENIERE DISEASE; MENTAL DISEASE; MOOD DISORDER; PHYSICAL DISEASE; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; SIDE EFFECT; SOMATOFORM DISORDER; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW; TINNITUS; UNSPECIFIED SIDE EFFECT;

FEMALE; HUMANS; MALE; PSYCHOPATHOLOGY; PSYCHOPHARMACOLOGY; TINNITUS;

EID: 84860371539     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.12.006     Document Type: Article

References (86)

1. Heller A.J. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am 2003, 36:239-248.
2. Holgers K.M., Zöger S., Svedlund J., Erlandsson S.I. Psychiatric profile of tinnitus patients referred to an audiology clinic. Proceedings of the Sixth International Tinnitus Seminar 1999, 283-285. The Tinnitus and Hyperacusis Centre, Cambridge, UK. J. Hazell (Ed.).
3. Laurikainen E., Johansson R., Akaan-Penttila E., Haapaniemi J. Treatment of severe tinnitus. Acta Otolaryngol Suppl 2000, 543:77-78.
4. Moller A.R. Neural plasticity in tinnitus. Prog Brain Res 2006, 157:365-372.
5. Axelsson A., Ringdahl A. Tinnitus: a study of its prevalence and characteristics. Br J Audiol 1989, 23:53-62.
6. Davis A.C. Hearing in adults 1995, 122-125. Whurr, London, UK.
7. Axelsson A., Ringdahl A. Tinnitus - a study of its prevalence and characteristics. Br J Audiol 1989, 23:53-62.
8. Brown R.D., Penny J.E., Henley C.M., Hodges K.B., Kupetz S.A., Glenn D.W., et al. Ototoxic drugs and noise. Ciba Found Symp 1981, 85:151-171.
9. Nicolas-Puel C., Akbaraly T., Lloyd R., Berr C., Uziel A., Rebillard G., et al. Characteristics of tinnitus in a population of 555 patients: specificities of tinnitus induced by noise trauma. Int Tinnitus J 2006, 12:64-70.
10. Dobie R.A. A review of randomized clinical trials in tinnitus. Laryngoscope 1999, 109:1202-1211.
11. Schleuning A.J. Management of the patient with tinnitus. Med Clin North Am 1991, 75:1225-1237.
12. Marciano E., Carrabba L., Giannini P., Sementina C., Verde P., Bruno C., et al. Psychiatric comorbidity in a population of outpatients affected by tinnitus. Int J Audiology 2003, 42:4-9.
13. Holgers K.M., Zöger S., Svedlund J. Predictive factors for severe tinnitus suffering: further characterisation. Int J Audiology 2005, 44:584-592.
14. Erlandsson S., Hallberg L., Axelsson A. Psychological and audiological correlates of perceived tinnitus severity. Audiology 1992, 31:168-179.
15. Collet L., Moussu M.F., Disant F., Ahami T., Morgon A. Minnesota Multiphasic Personality Inventory in tinnitus disorders. Audiology 1990, 28:101-106.
16. Harrop-Griffiths J., Katon W., Dobie R., Sakai C., Russo J. Chronic tinnitus: association with psychiatric diagnosis. J Psychosom Res 1987, 31:613-621.
17. Sullivan M.D., Katon W., Dobie R., Sakai C., Russo J. Disabling tinnitus: association with affective disorder. Gen Hosp Psychiatry 1988, 10:285-291.
18. Zöger S., Svedlund J., Holgers K.M. Psychiatric disorders in tinnitus patients without severe hearing impairment: 24-month follow-up of patients at an audiological clinic. Audiology 2001, 40:133-140.
19. Fioretti A., Eibenstein A., Fusetti M. New trends in tinnitus management. Open Neurol J 2011, 22:12-17.
20. Dobie R.A. Depression and tinnitus. Otolaryngol Clin N Am 2003, 36:383-388.
21. Sullivan M.D., Dobie R.A., Sakai C.S., Katon W.J. Treatment of depressed tinnitus patients with nortriptyline. Ann Otol Rhinol Laryngol 1989, 98:867-872.
22. Fornaro M., Martino M. Tinnitus psychopharmacology: a comprehensive review of its pathomechanisms and management. Neuropsychiatr Dis Treat 2010, 6:209-218.
23. Andersson G., McKenna L. Tinnitus masking and depression. Audiology 1998, 37:174-182.
24. Anderson G., Carlbring P., Kaldo V., Ström L. Screening of psychiatric disorders via the Internet. A pilot study with tinnitus patients. Nord J Psychiatry 2004, 58:287-291.
25. Langguth B., Kleinjung T., Fischer B., Hajak G., Eichhammer P., Sand P.G. Tinnitus severity, depression, and the big five personality traits. Prog Brain Res 2007, 166:221-225.
26. Adoga A.A., Adoga A.S., Obindo J.T. Tinnitus and the prevalence of co-morbid psychological stress. Niger J Med 2008, 17:95-97.
27. Weber J.H., Jagsch R., Hallas B. The relationship between tinnitus, personality, and depression. Z Psychosom Med Psychother 2008, 54:227-240.
28. Belli S., Belli H., Bahcebasi T., Ozcetin A., Alpay E., Ertem U. Assessment of psychopathological aspects and psychiatric comorbidities in patients affected by tinnitus. Eur Arch Otorhinolaryngol 2008, 265:279-285.
29. Schaaf H., Eipp C., Deubner R., Vasa R., Gieler U. Psychosocial aspects of coping with tinnitus and psoriasis patients. A comparative study of suicidal tendencies, anxiety and depression. HNO 2009, 57:57-63.
30. Langguth B., Landgrebe M., Kleinjung T., Sand G.P., Hajak G. Tinnitus and depression. World J Biol Psychiatry 2011, 12:489-500.
31. Asplund R. Sleepiness and sleep in elderly persons with tinnitus. Arch Gerontol Geriatr 2003, 37:139-145.
32. Alster J., Shemesh Z., Ornan M., Attias J. Sleep disturbance associated with chronic tinnitus. Biol Psychiatry 1993, 34:84-90.
33. Folmer R.L., Griest S.E. Tinnitus and insomnia. Am J Otolaryngol 2000, 21:287-293.
34. Holgers K.M., Erlandsson S.I., Barrenäs M.L. Predictive factors for the severity of tinnitus. Audiology 2000, 39:284-291.
35. Nondahl D.M., Cruickshanks K.J., Wiley T.L., Klein R., Klein B.E., Tweed T.S. Prevalence and 5-year incidence of tinnitus among older adults: the epidemiology of hearing loss study. J Am Acad Audiol 2002, 13:323-331.
36. Langenbach M., Olderog M., Michel O., Albus C., Köhle K. Psychosocial and personality predictors of tinnitus-related distress. Gen Hosp Psychiatry 2005, 27:73-77.
37. Hébert S., Paiement P., Lupien S.J. A physiological correlate for the intolerance to both internal and external sounds. Hear Res 2004, 190:1-9.
38. Hébert S., Lupien S.J. The sound of stress: blunted cortisol reactivity to psychosocial stress in tinnitus sufferers. Neurosci Lett 2007, 411:138-142.
39. Crönlein T., Langguth B., Geisler P., Hajak G. Tinnitus and insomnia. Prog Brain Res 2007, 166:227-233.
40. Andersson G., Porsaeus D., Wiklund M., Kaldo V., Larsen H.C. Treatment of tinnitus in the elderly: a controlled trial of cognitive behavior therapy. Int J Audiol 2005, 44:671-675.
41. Newman C.W., Jacobson G.P., Spitzer J.B. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 1996, 122:143-148.
42. Wilson P.H., Henry J., Bowen M., Haralambous G. Tinnitus reaction questionnaire: psychometric properties of a measure of distress associated with tinnitus. J Speech Hear Res 1991, 34:197-201.
43. Kuk F.K., Tyler R.S., Russell D., Jordan H. The psychometric properties of a tinnitus handicap questionnaire. Ear Hear 1990, 11:434-445.
44. Baldo P., Doree C., Lazzarini R., Molin P., McFerran D.J. Antidepressants for patients with tinnitus. Cochrane Database Syst Rev 2006, (4):CD003853.
45. Robinson S. Antidepressants for treatment of tinnitus. Prog Brain Res 2007, 166:263-271.
46. Dobie R.A., Sullivan M.D., Katon W.J., Sakai C.S., Russo J. Antidepressant treatment of tinnitus patients. Interim report of a randomized clinical trial. Acta Otolaryngol 1992, 112:242-247.
47. Mendis D., Johnston M. An unusual case of prolonged tinnitus following low-dose amitriptyline. J Psychopharmacol 2008, 22:574-575.
48. Podoshin L., Ben-David Y., Fradis M., Malatskey S., Hafner H. Idiopathic subjective tinnitus treated by amitriptyline hydrochloride/biofeedback. Int Tinnitus J 1995, 1:54-60.
49. Bayar N., Böke B., Turan E., Belgin E. Efficacy of amitriptyline in the treatment of subjective tinnitus. J Otolaryngol 2001, 30:300-303.
50. Dib G.C., Kasse C.A., Alves de Andrade T., Gurgel Testa J.R., Cruz O.L. Tinnitus treatment with trazodone. Braz J Otorhinolaryngol 2007, 73:390-397.
51. Marais J. Cochleotoxicity due to mianserin hydrochloride. J Laryngol Otol 1991, 105:475-476.
52. Leiter F.L., Nierenberg A.A., Sanders K.M., Stern T.A. Discontinuation reactions following sertraline. Biol Psychiatry 1995, 38:694-695.
53. Zoger S., Svedlund J., Holgers K.M. The effects of sertraline on severe tinnitus suffering - a randomized double-blind placebo-controlled study. J Clin Psychopharmacol 2006, 26(1):32-39.
54. Salvi R., Lobarinas E., Sun W. Pharmacological treatments for tinnitus: new and old. Drugs Future 2009, 34:381-400.
55. Pondrom M.F., Brahm N.C. Venlafaxine-associated tinnitus. Am J Health Syst Pharm 2009, 66:1606-1608.
56. Ahmad S. Venlafaxine and severe tinnitus. Am Fam Physician 1995, 51:1830.
57. De Marinis M., Santilli V. Tinnitus in postherpetic neuralgia. J Headache Pain 2010, 11:83-84.
58. D'Amelio R., Delb W. Comorbidity of schizophrenic psychosis and tinnitus. A hitherto neglected theme in research and therapy. HNO 2008, 56:670-672.
59. Lopez-Gonzalez M.A., Moliner-Peiro F., Alfaro-Garcia J., Esteban-Ortega F. Sulpiride plus hydroxyzine decrease tinnitus perception. Auris Nasus Larynx 2007, 34:23-27.
60. Hulshof J.H., Vermeij P. The value of carbamazepine in the treatment of tinnitus. ORL J Otorhinolaryngol Relat Spec 1985, 47:262-266.
61. Sanchez T.G., Balbani A.P., Bittar R.S., Bento R.F., Câmara J. Lidocaine test in patients with tinnitus: rationale of accomplishment and relation to the treatment with carbamazepine. Auris Nasus Larynx 1999, 26:411-417.
62. Zheng Y., Hooton K., Smith P.F., Darlington C. Carbamazepine reduces the behavioural manifestations of tinnitus following salicylate treatment in rats. Acta Otolaryngol 2008, 128:48-52.
63. She W., Dai Y., Du X., Ding X., Cui X. Treatment of subjective tinnitus: a comparative clinical study of intratympanic steroid injection vs. oral carbamazepine. Med Sci Monit 2009, 15:135-139.
64. Mansbach A.L., Freyens P. Tinnitus: current data and treatment with sodium valproate. Acta Otorhinolaryngol Belg 1983, 37:697-705.
65. Menkes D.B., Larson P.M. Sodium valproate for tinnitus. J Neurol Neurosurg Psychiatry 1998, 65:803.
66. Simpson J.J., Gilbert A.M., Weiner G.M., Davies W.E. The assessment of lamotrigine an antiepileptic drug in the treatment of tinnitus. Am J Otol 1999, 20:627-631.
67. Bauer C.A., Brozoski T.J. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 2006, 116:675-681.
68. Witsell D.L., Hannley M.T., Stinnet S., Tucci D.L. Treatment of tinnitus with gabapentin: a pilot study. Otol Neurotol 2007, 28:11-15.
69. Piccirillo J.F., Finnell J., Vlahiotis A., Chole R.A., Spitznagel E. Relief of idiopathic subjective tinnitus: is gabapentin effective?. Arch Otolaryngol Head Neck Surg 2007, 133:390-397.
70. Daftary A., Shulman A., Strashun A Gottschalk C., Zoghbi S.S., Seibyl J.P. Benzodiazepine receptor distribution in severe intractable tinnitus. Int Tinnitus J 2004, 10:17-23.
71. Jalali M.M., Kousha A., Naghavi S.E., Soleimani R., Banan R. The effects of alprazolam on tinnitus: a cross-over randomized clinical trial. Med Sci Monit 2009, 15:I55-60.
72. Panford-Walsh R., Singer W., Rüttiger L., Hadjab S., Tan J., Geisler H.S., et al. Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and Arg3.1 expression: implications for tinnitus perception and auditory plasticity. Mol Pharmacol 2008, 74:595-604.
73. Ganança M.M., Caovilla H.H., Ganança F.F., Ganança C.F., Munhoz M.S., da Silva M.L., et al. Clonazepam in the pharmacological treatment of vertigo and tinnitus. Int Tinnitus J 2002, 8:50-53.
74. Johnson R.M., Brummett R., Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 1993, 119:842-854.
75. Busto U., Fornazzari L., Naranjo C.A. Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines. J Clin Psychopharmacol 1988, 8:359.
76. Busto U., Sellers E.M., Naranjo C.A., Cappell H., Sanchez-Craig M., Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. New Engl J Med 1986, 315:854.
77. Albertino S., Assuncao A.R., Souza J.A. Pulsatile tinnitus: treatment with clonazepam and propranolol. Braz J Otorhinolaryngol 2005, 71:111-113.
78. Puel J.L. Cochlear NMDA receptor blockade prevents salicylate-induced tinnitus. B-ENT 2007, 3(Suppl 7):19-22.
79. Guitton M.J., Caston J., Ruel J., Johnson R.M., Pujol R., Puel J.L. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci 2003, 23:3944-3952.
80. Guitton M.J., Dudai Y. Blockade of cochlear NMDA receptors prevents long-term tinnitus during a brief consolidation window after acoustic trauma. Neural Plast 2007, 2007:80904.
81. Pomara N., Ott B.R., Peskind E., Resnick E.M. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial. Alzheimer Dis Assoc Disord 2007, 21:60-64.
82. Oliver D., Ludwig J., Reisinger E., Zoellner W., Ruppersberg J.P., Fakler B. Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells. Mol Pharmacol 2001, 60:183-189.
83. Denk D.M., Heinzl H., Franz P., Ehrenberger K. Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngol 1997, 117:825-830.
84. Ehrenberger K. Topical administration of caroverine in somatic tinnitus treatment: proof-of-concept study. Int Tinnitus J 2005, 11:34-37.
85. Azevedo A.A., Figuerido R.R. Tinnitus treatment with acamprosate: double-blind study. Braz J Otorhinolaryngol 2005, 71:618-623.
86. Langguth B., Goodey R., Azevedo A., et al. Consensus for tinnitus patient assessment and treatment outcome measurement. Tinnitus: pathophysiology and treatment 2007, 529-531. Elsevier, Amsterdam. B. Langguth, G. Hajak, T. Kleinjung, A.T. Cacace, A.R. Møller (Eds.).